Imperagen’s £5M raise brings quantum-AI methods into enzyme engineering

Biology is becoming one of the most interesting markets for AI because better prediction can reduce expensive trial and error.

What happened

Imperagen raised £5M to use quantum physics and AI methods for enzyme engineering.

Why it matters

Enzyme engineering touches industrial biotech, chemicals, agriculture, and drug development. If AI can improve design cycles, it could make biological engineering faster and cheaper.

The bigger picture

The most compelling AI biotech companies may not be general-purpose. They may focus on narrow scientific workflows where better modelling directly improves lab outcomes.